Bumper Offer - Urjas oil Just @ Rs. 1
Dinace 5 Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Muscle Pain, Toothache, Rheumatic Pain. Secondary and off-label uses of Dinace 5 Tablet have also been mentioned below.
The right dosage of Dinace 5 Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Dinace 5 Tablet have been listed ahead. Normally, these side effects of Dinace 5 Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Dinace 5 Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. In addition, Dinace 5 Tablet's effects on the liver, heart and kidney are discussed below in the Dinace 5 Tablet related warnings section.
Dinace 5 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Dinace 5 Tablet in conditions like Stomach Infection, Skin Rash, Stroke. Other conditions have been mentioned below in the Dinace 5 Tablet contraindications section.
Besides this, Dinace 5 Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Dinace 5 Tablet, it is important to know that it is safe while driving, and is habit-forming.
Dinace 5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Dinace 5 Tablet is used -
Severe
Moderate
Mild
Is the use of Dinace 5 Tablet safe for pregnant women?
Dinac should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Dinace 5 Tablet safe during breastfeeding?
Side effects of Dinac for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Dinace 5 Tablet on the Kidneys?
Consumption of Dinac can harm the kidneys. So it is important to take medical advice beforehand.
What is the effect of Dinace 5 Tablet on the Liver?
Dinac may have severe effects on your liver, so do not take it without first consulting your doctor.
What is the effect of Dinace 5 Tablet on the Heart?
The heart can be affected by Dinac. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Dinace 5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Dinace 5 Tablet unless your doctor advises you to do so -
Is this Dinace 5 Tablet habit forming or addictive?
Forming a habit of Dinace 5 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Dinace 5 Tablet since it will not make you feel sleepy.
Is it safe?
Yes, Dinace 5 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Dinace 5 Tablet is not used to treat mental disorders.
Interaction between Food and Dinace 5 Tablet
Due to the absence of research, it is difficult to say how Dinace 5 Tablet and food will interact.
Interaction between Alcohol and Dinace 5 Tablet
Consult your doctor before consuming alcohol while taking Dinace 5 Tablet as it can have severe side effects.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Kemadrin (procyclidine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 433
